Synthesis and Activity of New Schiff Bases of Furocoumarin

Abstract Furocoumarins, such as 8-MOP, are the most common medications used to relieve the symptoms of vitiligo clinically. Some furocoumarins also showed excellent performance in an anti-bacterial assay. This paper describes the synthesis of a series of novel Schiff bases (6a-6k), and their promotion in melanogenesis and anti-bacterial properties were studied in vitro. The pigment production of B16 cells and bacterial inhibition ring assay were applied for the bioactivity of 6a-6k. According to the results, a stronger promotion on pigment content was observed, when six compounds co-cultured with cells, compared with positive control (8-MOP). Significantly, compound 6k (237%) as the most active was found to increase the amount of melanin more than 1.7 times compared with 8-MOP activation rate (136%). All the compounds could moderately retard C. albicans growth. Interestingly, aldehyde 5, which possessed a broader antibacterial spectrum, showed the highest inhibition against C. albicans as well and much better than the positive control (Amphotericin B). Studies of 6k in animal models of vitiligo and related molecular mechanism are presently under way, with the aim of discovering an anti-vitiligo leading compound.

[1]  H. Aisa,et al.  Preparation of novel 1,2,3-triazole furocoumarin derivatives via click chemistry and their anti-vitiligo activity , 2019, RSC advances.

[2]  L. Yin,et al.  Novel Furocoumarin Derivatives Stimulate Melanogenesis in B16 Melanoma Cells by Up-Regulation of MITF and TYR Family via Akt/GSK3β/β-Catenin Signaling Pathways , 2018, International journal of molecular sciences.

[3]  H. Aisa,et al.  Two new compounds from the seeds of Vernonia anthelmintica , 2017, Journal of Asian natural products research.

[4]  A. Eblimit,et al.  Isochlorogenic acid A promotes melanin synthesis in B16 cell through the &bgr;-catenin signal pathway , 2017, Acta biochimica et biophysica Sinica.

[5]  C. Dong,et al.  Design, synthesis and bioactivity of chalcones and its analogues , 2017 .

[6]  K. Ezzedine,et al.  New discoveries in the pathogenesis and classification of vitiligo. , 2017, Journal of the American Academy of Dermatology.

[7]  H. Aisa,et al.  Synthesis and biological evaluation of furocoumarin derivatives on melanin synthesis in murine B16 cells for the treatment of vitiligo. , 2016, Bioorganic & medicinal chemistry.

[8]  L. Yin,et al.  Synthesis and bioactivity of novel isoxazole chalcone derivatives on tyrosinase and melanin synthesis in murine B16 cells for the treatment of vitiligo. , 2016, Bioorganic & medicinal chemistry.

[9]  A. Christiano,et al.  Rapid skin repigmentation on oral ruxolitinib in a patient with coexistent vitiligo and alopecia areata (AA). , 2016, Journal of the American Academy of Dermatology.

[10]  J. Woo,et al.  Hyperpigmentation mechanism of methyl 3,5-di-caffeoylquinate through activation of p38 and MITF induction of tyrosinase. , 2015, Acta biochimica et biophysica Sinica.

[11]  J. Richmond,et al.  Innate immune mechanisms in vitiligo: danger from within. , 2013, Current opinion in immunology.

[12]  Abdullah W. Mohammed,et al.  Repair efficiency and PUVA therapeutic response variation in patients with vitiligo. , 2013, Toxicology in vitro : an international journal published in association with BIBRA.

[13]  J. Munoz-Munoz,et al.  Action of tyrosinase on ortho-substituted phenols: possible influence on browning and melanogenesis. , 2012, Journal of agricultural and food chemistry.

[14]  M. Picardo,et al.  Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference , 2012, Pigment cell & melanoma research.

[15]  R. Sánchez-Porras,et al.  Immunopathogenesis of vitiligo. , 2011, Autoimmunity reviews.

[16]  Meaghan Daly,et al.  Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. , 2011, Journal of the American Academy of Dermatology.

[17]  Lesley M Felsten,et al.  Vitiligo: a comprehensive overview Part II: treatment options and approach to treatment. , 2011, Journal of the American Academy of Dermatology.

[18]  B. Dijkstra,et al.  Crystal structure of Agaricus bisporus mushroom tyrosinase: identity of the tetramer subunits and interaction with tropolone. , 2011, Biochemistry.

[19]  Bang-le Zhang,et al.  Structural modification of a specific antimicrobial lead against Helicobacter pylori discovered from traditional Chinese medicine and a structure-activity relationship study. , 2010, European journal of medicinal chemistry.

[20]  Maria I Barona,et al.  Update on skin repigmentation therapies in vitiligo , 2009, Pigment cell & melanoma research.

[21]  S. Pillai,et al.  Grapefruit juice and its furocoumarins inhibits autoinducer signaling and biofilm formation in bacteria. , 2008, International journal of food microbiology.

[22]  A. Chan,et al.  Synthesis and biological evaluation of functionalized coumarins as acetylcholinesterase inhibitors. , 2005, European journal of medicinal chemistry.

[23]  M. M. Rahman,et al.  Antibacterial compounds from the seeds of Psoralea corylifolia. , 2004, Fitoterapia.

[24]  Paul Meredith,et al.  Radiative Relaxation Quantum Yields for Synthetic Eumelanin¶ , 2003, Photochemistry and photobiology.

[25]  W. L. Fowlks,et al.  Photosensitization of Bacteria by Furocoumarins and Related Compounds , 1958, Nature.